Scrip’s Five Must-Know Things – 23 October 2023

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: Daiichi’s huge ADC deal with Merck; mixed data for Rybrevant at ESMO; Pfizer girds for cost cuts; myeloma helps J&J’s Q3; and five key points for cell and gene Meeting on the Mesa. https://scrip.citeline.com/SC149230/Quick-Listen-Scrips-Five-MustKnow-Things